Health officials across parts of Asia have moved quickly to reintroduce COVID-era airport screening after a confirmed outbreak of the deadly Nipah virus, an infection with no approved cure and a history of high fatality rates.
The response follows confirmed cases in India’s West Bengal region, where patients were hospitalized after developing severe symptoms that escalated far beyond common viral illness, according to regional reporting.
Nipah is not new, but it remains one of the most feared zoonotic viruses tracked by global health agencies. The World Health Organization has repeatedly classified it as a priority pathogen due to its ability to cause rapid neurological decline and its lack of targeted treatment options.
Unlike respiratory viruses that spread widely before causing serious illness, Nipah is especially dangerous because early symptoms can appear mild before abruptly progressing to encephalitis, or inflammation of the brain, as outlined in clinical guidance.
Patients often begin with fever, headaches, muscle pain, and fatigue, but in severe cases may quickly experience confusion, seizures, and loss of consciousness, a progression that has alarmed hospital staff monitoring recent cases.
That risk has pushed airport authorities to act preemptively. Several international hubs have reinstated temperature checks, visible health monitoring, and targeted screening for travelers arriving from affected regions, measures that mirror early COVID travel controls.
